NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain

Behavioural Brain Research

Volumn 232, Issue 1, 2012, Pages 93-97

  Smith, Kristin E ^a   Boules, Mona ^a   Williams, Katrina ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

Author keywords

Analgesia; NT69L; NT72; NT79; Tolerance; Writhing

Indexed keywords

LEVOCABASTINE; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; NT69L; NT72; NT79; PROTEIN NTS1; PROTEIN NTS2; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VISCERAL PAIN; WILD TYPE; WRITHING TEST;

ACETIC ACID; ANALGESIA; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; HISTAMINE H1 ANTAGONISTS; MICE; MICE, KNOCKOUT; NEUROTENSIN; PAIN; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PIPERIDINES; RECEPTORS, NEUROTENSIN;

EID: 84859929441     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.03.044     Document Type: Article

References (31)

1. Carraway R., Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. Journal of Biological Chemistry 1973, 248:6854-6861.
2. Boules M., Fredrickson P., Richelson E. Bioactive analogs of neurotensin. Peptides 2006, 27:2523-2533.
3. Boules M., Liang Y., Briody S., Miura T., Fauq I., Oliveros A., et al. NT79: a novel neurotensin analog with selective behavioral effects. Brain Research 2010, 1308:35-46.
4. Boules M., Fredrickson P., Richelson E. Current topics: brain penetrating neurotensin analog. Life Sciences 2003, 73:2785-2792.
5. Tyler-McMahon B.M., Stewart J.A., Farinas F., McCormick D.J., Richelson E. Highly potent neurotensin analog that causes hypothermia and antinociception. European Journal of Pharmacology 2000, 390:107-111.
6. Boules M., Shaw A., Liang Y., Barbut D., Richelson E. NT69L, a novel analgesic, shows synergy with morphine. Brain Research 2009, 1294:22-28.
7. Fantegrossi W.E., Ko M.C.H., Woods J.H., Richelson E. Pharmacological effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacology Biochemistry & Behavior 2005, 80:341-349.
8. Smith K.E., Boules M., Williams K., Fauq A.H., Richelson E. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia. Behavioural Brain Research 2011, 244(2):344-349.
9. Roussy G., Dansereau M-A., Doré-Savard L., Belleville K., Beaudet N., Richelson E., et al. Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model. Journal of Neurochemistry 2008, 105:1100-1114.
10. Dubuc I., Remande S., Costentin J. The partial agonist properties of levocabastine in neurotensin-induced analgesia. The European Journal of Pharmacology 1999, 381:9-12.
11. Dubuc I., Sarret P., Labbe-Jullie C., Botto J.M., Honore E., Bourdel E., et al. Identification of the receptor subtype involved in the analgesic effect of neurotensin. Journal of Neuroscience 1999, 19:503-510.
12. Remaury A., Vita N., Gendreau S., Jung M., Arnone M., Poncelet M., et al. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Research 2002, 953:63-72.
13. International Patent No. 11/8000,975, Publication No. (Richelson E, McCormick D, Pang Y-P, Phillips KS). Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2.
14. Mechanic J.A., Sutton J.E., Berson A.E., Wu X., Kwan J., Schreiber R., et al. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice. European Neuropsychopharmacology 2009, 19:466-475.
15. Fauq A.H., Hong F., Cusack B., Tyler B.M., Pang Y.P., Richelson E. Synthesis of (2S)-2-amino-3-(1H-4-indolyl) propanoic acid, a novel trryptophan analog for structural modification of bioactive peptides. Tetrahedron: Asymmetry 1998, 9:4127-4134.
16. Rossi G.C., Matulonis J.E., Richelson E., Barbut D., Pasternak G.W. Systemically and topically active antinociceptive neurotensin compounds. Journal of Pharmacology and Experimental Therapeutics 2010, 334:1075-1079.
17. Lambert P.D., Ely T.D., Gross R.E., Kilts C.D. Neurotensin induces Fos and Zif268 expression in limbic nuclei of the rat brain. Neuroscience 1996, 75:1141-1151.
18. Tasaka K., Kamei C., Tsujimoto S., Yoshida T., Aoki I. Central effect of the potent long-acting H1-antihistamine levocabastine. Arzneimittelforschung 1990, 40:1295-1299.
19. Liang Y., Boules M., Li Z., Williams K., Miura T., Oliveros A., et al. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice. Neuropharmacology 2010, 58:1199-1205.
20. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., et al. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. Journal of Pharmacology and Experimental Therapeutics 2002, 300:305-313.
21. Tyler B.M., Groshan K., Cusack B., Richelson E. In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinociception. Brain Research 1998, 787:78-84.
22. Hwang J.R., Baek M.W., Sim J., Choi H.S., Han J.M., Kim Y.L., et al. Intermolecular cross-talk between NTR1 and NTR2 neurotensin receptor promotes intracellular sequestration and functional inhibition of NTR1 receptors. Biochemical and Biophysical Research Communications 2010, 391:1007-1013.
23. Perron A., Sharif N., Sarret P., Stroh T., Beaudet A. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization. Biochemical and Biophysical Research Communications 2007, 353:582-590.
24. Martin S., Navarro V., Vincent J.P., Mazella J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 2002, 123:1135-1143.
25. Bissette G., Nemeroff C.B., Loosen P.T., Prange A.J., Lipton M.A. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature 1976, 262:607-609.
26. Lapo I.B., Konarzewski M., Sadowski B. Analgesia induced by swim stress: interaction between analgesic and thermoregulatory mechanisms. Pflügers Archiv: European Journal of Physiology 2003, 446:463-469.
27. Suckow M.A., Terril L.A., Grigdesby C.F., March P.A. Evaluation of hypothermia-induced analgesia and influence of opioid antagonists in leopard frogs (Rana pipiens). Pharmacology Biochemistry and Behavior 1999, 63:39-43.
28. Sadowski B., Konarzewski M. Analgesia in selectively bred mice exposed to cold in helium/oxygen atmosphere. Physiology & Behavior 1999, 66:145-151.
29. Tyler B.M., Douglas C.L., Fauq A., Pang Y.P., Stewart J.A., Cusack B., et al. In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier. Neuropharmacology 1999, 38:1027-1034.
30. Boules M., McMahon B., Warrington L., Stewart J., Jackson J., Fauq A., et al. Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. Brain Research 2001, 919:1-11.
31. Tyler B.M., Cusack B., Douglas C.L., Souder T., Richelson E. Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception. Brain Research 1998, 792:246-252.